Project Grant HT94252510118
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$510K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This $489,065 Project Grant was awarded by the Defense Health Agency on July 1, 2025 under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award funds research at the University of North Carolina at Chapel Hill (UNC-CH) to develop "Potentiated Chip Variants as Therapeutics to Alleviate Tau Pathology and Neurodegeneration". The research aims to explore innovative approaches to preventing, diagnosing, and treating neurodegenerative conditions,...
This $1,100,633 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports cancer research and translational science initiatives at the University of North Carolina at Chapel Hill (UNC-CH). Specifically, the award will fund innovative biomedical research projects focused on transforming healthcare for military service members and the broader public. Research areas may include disease prevention, diagnosis, treatment, and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $2,826,619.00 to the University of North Carolina at Chapel Hill (UNC-CH) for the research and development of a sublingual formulation of dexmedetomidine to prevent and reduce the incidence of acute stress reactions, autism spectrum disorder, and post-traumatic stress disorder in order to sustain warfighter performance. The award has a performance...
The University of North Carolina at Chapel Hill received a $1,555,000 Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will fund a 3-year research project to measure the autonomic nervous system responses of warfighters following exertion and resting stressors. This research aims to advance understanding of how the autonomic nervous system is impacted by physical and psychological stressors...
This $544,250 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of North Carolina at Chapel Hill to develop combination therapies to overcome chemoresistance in Ewing sarcoma. The research project, which has a performance period from August 15, 2024 to August 14, 2027, aims to advance innovative therapeutic approaches to improve outcomes for this rare and aggressive form of cancer. As a...
This $311,000 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support the University of North Carolina at Chapel Hill (UNC-CH) in enhancing clinical trial discovery, matching, and enrollment for pancreatic ductal adenocarcinoma (PDAC) using fine-tuned large language models. The award, which runs from November 1, 2024 to October 31, 2026, will enable UNC-CH to develop innovative...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,511,536.00 to the University of North Carolina at Chapel Hill (UNC-CH) to conduct a Testis Cancer Survivorship Study. The award period runs from July 1, 2024 to June 30, 2028. UNC-CH, through its Office of Sponsored Research, will execute this biomedical research initiative to transform healthcare for military service members and...
The University of North Carolina at Chapel Hill was awarded a $1,200,470 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into pathogenic T cells in Guillain-Barré syndrome from September 30, 2021 through September 29, 2025. As part of the Military Medical Research and Development program's goals of transforming military and public health through innovative medical research and...
The University of North Carolina at Chapel Hill will use a $777,500 Project Grant from the Defense Health Agency to support research aimed at reducing expression of TDP-43 protein in amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The grant was awarded on April 15, 2023 under the Military Medical Research and Development program (CFDA 12.420). Through April 14, 2025, UNC-Chapel Hill researchers will investigate medical solutions for ALS at the project site in Chapel...
The University of North Carolina at Chapel Hill will receive $3,863,892 under a four-year Project Grant from the Defense Health Agency to integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The grant, awarded on September 15, 2023 under the Military Medical Research and Development program, will support the university's efforts to transform military and public health care by investigating medical solutions for the battlefield and innovative research...